Navigation Links
Leak Detection Associates to Serve as Technical Presenter at PDA Europe CCIT Training Course
Date:12/23/2019

Leak Detection Associates, the leading global supplier of helium based leak detection systems for the Pharmaceutical, Biotechnology and Medical Device Industries, is excited to announce that it will be a contributing instrument manufacturer and technical presenter at the Parenteral Drug Association (PDA) Container Closure Integrity Testing Basic Training Course. Held in conjunction with PDA Europe’s 10th Parenteral Packaging Conference, the two-day training program encompasses presentations on theory and real-life applications of all deterministic container closure integrity test (CCIT) technologies referenced in USP 1207. Critically, participating attendees are given the opportunity to witness demonstrations of actual instrumentation, with the unique opportunity for hands-on use in an engaging and learning-based environment.

The PDA 10th Parenteral Packaging Conference will be held in Basel, Switzerland on February 25th & 26th and the CCI specific training course is scheduled to follow on February 26th & 27th. Presenting on behalf of Leak Detection Associates will be Brian Mulhall, CEO and former Founder/President of Whitehouse Analytical Laboratories, while Jeff Morrow Lucas, LDA’s Director of Engineering, will host the hands-on technical training for attendees. In support of these technical presentations and hands-on activities, Leak Detection Associates will be providing its newest model, the SIMS 1915+ Helium Leak Detection System. Attendees will gain an understanding of how the system can be used to establish inherent integrity, optimize manufacturing, and more for a range of package systems and at extreme levels of sensitivity. LDA will also be featuring its new, low temperature add-on system that enables analysis of packages down to -80°C, critical for product-packages stored at these aggressive temperatures.

“We are extremely excited to be part of this highly educational event to specifically represent a key test method for container and package integrity testing specific to USP 1207 requirements,” commented Brian Mulhall, LDA’s CEO. “For more than 20 years, Leak Detection Associates has held a leadership role in the development and use of helium technology for container leak testing and having the opportunity to advance our knowledge and experience as part of a unique training seminar such as this will enable the value of helium leak testing to be shared with many relevant participants who are looking for CCI solutions in this highly regulated area.”

This course focuses on theoretical and practical fundamentals of various CCI testing technologies and provides a systematic approach to apply these testing methods for CCI verification throughout drug product lifecycles. The course, as a whole, will enable the participants to implement CCI testing strategies to ensure adequate drug product protection and be compliant with relevant regulatory and compendial requirements. In this course, participants gain critical problem-solving skills through:

  •     Interactive discussions with a panel of cross-functional technical experts consisting of CCI testing laboratory experts, testing instrument suppliers/manufacturers, and pharmaceutical packaging development engineers
  •     Hands-on testing training on the newest innovations and state-of-the-art instruments
  •     Real-world case studies

Being held in conjunction with the 10th Parenteral Packaging Conference, this training course will utilize lectures, case studies, and interactive hands-on training on testing instruments to provide insight into the latest developments of Container Closure Integrity (CCI) Testing. It is expected that participants will develop an understanding of the most up-to-date regulatory and pharmacopeia requirements on CCIT while learning how to define CCI requirements for various container and drug product types using a risk-based approach. The key focus will be on practical applications using the deterministic methods such as tracer gas detection (e.g. helium leak detection), electrical conductivity and capacitance (HVLD), vacuum decay leak detection, laser-based gas headspace analysis, and mass extraction leak tests. Other key topic areas to be covered include selecting and applying appropriate testing methods for both laboratory and in-process testing to formulate comprehensive package integrity verification profiles, defining CCI testing method development and validation approaches and best practices, and avoiding common issues and pitfalls in CCI testing applications. To learn more about the conference and to register for attendance at this valuable training course, please visit http://www.pda.org.

About Leak Detection Associates, LLC
For over 20 years, Leak Detection Associates has been the premier manufacturer of custom helium leak detection instruments for the pharmaceutical, biotechnology, medical device and food packaging industries. LDA's well-established technology has been incorporated into ASTM and compendial guidance documents. This robust industry experience, combined with the advanced capabilities of its newest model, the SIMS 1915+ helium leak detection unit, provides companies with tools to quantitatively evaluate leakage, improve the package development cycle, establish manufacturing controls, and ultimately reduce risk to the product and consumer throughout the lifecycle.

Read the full story at https://www.prweb.com/releases/leak_detection_associates_to_serve_as_technical_presenter_at_pda_europe_ccit_training_course/prweb16803835.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Leak Detection Associates Announces New SIMS 1915+ Low Temperature -80C Helium Leak Testing System
2. Leak Detection Associates Announces Expansion to Chinese Market – Partnership Agreement Signed With Shanghai Zillion
3. Leak Detection Associates Announces Release of New Heliumleak.com Website
4. Leak Detection Associates Names Key Executives to Leadership Roles
5. ExcitePCR Announces its FireflyDX-Portable: A Lightweight, Bookbag-sized Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018
6. Bio-Tech Firm PathSensors Enters Fast-Growing Chinese Pathogen Detection Market
7. Cynvenio and Saint Luke’s Cancer Institute Launch Pilot Study to Evaluate the Potential for Early Detection of Recurrent Breast Cancer Following Therapy
8. angelMD Completes Investment in Bleeding Detection Medical Device Company
9. SCIEX Explores Allergen Detection and Authenticity Testing of Food in New Webinar
10. Agena Bioscience Explores a More Reliable Detection of Low Abundance Somatic Mutations in New Webinar
11. PolySkope Labs Announces AOAC PTM Submission of the Worlds First Comprehensive Multiplex Pathogen Detection Method for Food Safety Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/13/2020)... ... March 12, 2020 , ... Today, DuPont Nutrition & Biosciences ... (APC), a pioneer in the field of microbiome science, which focuses on microbes ... human health, based at University College Cork and Teagasc Moorepark. , Representatives from ...
(Date:3/10/2020)... ... March 10, 2020 , ... ... chain biopharmaceutical engineering firm, is pleased to announce the addition of Carson ... medical device qualification and validation in the biopharmaceutical cold chain. He provides ...
(Date:3/4/2020)... ... March 04, 2020 , ... This month, Cognosante will make its annual ... will showcase both expanded and emerging offerings that align with the HIMSS annual theme, ... to be comprehensive, timely, and engaging. From Interoperability and HIE to ...
(Date:3/2/2020)... ... March 02, 2020 , ... McBee, Moore and Vanik IP, LLC (MMV IP) ... of Biotechnology and Organics. , According to statistics compiled by Harrity Anaytics, MMV IP ... in technology center 1600 during 2019. Technology center 1600 at the US Patent Office ...
Breaking Biology Technology:
(Date:3/2/2020)... ... , ... Philadelphia IP law firm Panitch Schwarze Belisario & Nadel LLP is ... a Partner, and Stephany G. Small, Ph.D., has joined the firm as a patent ... partner in the firm’s biotechnology and life science practice group. He has significant experience ...
(Date:2/28/2020)... ... February 26, 2020 , ... ... Rebound PRP™ and Rebound PRF® devices are now available to veterinary practices ... regenerative medical devices, that will provide the most affordable, easiest to use, ...
(Date:2/28/2020)... SCOTTSDALE, Ariz. (PRWEB) , ... February 28, 2020 ... ... a 20% discount on initial biologics orders. This includes all available stem cell ... products, including amniotic and umbilical tissue, Exosome Biologics, PRP kits, adipose kits, PDO ...
Breaking Biology News(10 mins):